Company profile
Hertility
Join the #ReproductiveRevolution!
- Industry
- Biotechnology Research
- Employees
- 86
- Headquarters
- London
- Founded
- 2019
- Office locations
- 1
Hertility company summary
Hertility is a company in the Biotechnology Research industry, headquartered in London, founded in 2019. On LinkedIn the company has around 86 employees. Its listed specialties include Women's Health, Hormone Health, Fertility, Menopause, Research.
What technology does Hertility use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Hertility
Hertility is a data-driven women’s health platform combining advanced diagnostics, proprietary AI-powered clinical decision support, and end-to-end care to enable earlier, faster, and more accurate detection and treatment across the female lifespan. Hertility has built the world’s largest multimodal dataset in women’s health, powering a clinical-grade AI diagnostic that screens for 25 health states (including 18 conditions) with 98–99% precision, validated across 29 research studies. This is paired with a Software as a Medical Device (SaMD) and integrated patient management system that automates clinical workflows, including AI-assisted ultrasound interpretation and automated reporting, enabling clinicians to scale care delivery efficiently. In the next 6 months, alongside the NVIDIA inception programme, they will scale globally and initiate the first foundational AI model for women’s health. We’re calling this the Reproductive Revolution!
Specialties
Where is Hertility located?
Hertility lists 1 location.
Compare companies similar to Hertility
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Hertility hertilityhealth.com | Biotechnology Research | 86 | 2019 | London |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Hertility
What does Hertility do?
Hertility is a data-driven women’s health platform combining advanced diagnostics, proprietary AI-powered clinical decision support, and end-to-end care to enable earlier, faster, and more accurate detection and treatment across the female lifespan. Hertility has built the world’s largest multimodal dataset in women’s health, powering a clinical-grade AI diagnostic that screens for 25 health states (including 18 conditions) with 98–99% precision, validated across 29 research studies. This is paired with a Software as a Medical Device (SaMD) and integrated patient management system that automates clinical workflows, including AI-assisted ultrasound interpretation and automated reporting, enabling clinicians to scale care delivery efficiently. In the next 6 months, alongside the NVIDIA inception programme, they will scale globally and initiate the first foundational AI model for women’s health. We’re calling this the Reproductive Revolution!
How many employees does Hertility have?
Hertility has around 86 employees on LinkedIn.
Where is Hertility headquartered?
Hertility is headquartered in London.
When was Hertility founded?
Hertility was founded in 2019.
Build a lead list from companies like Hertility
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.